1st new TB vaccine in 100 years advances as organisations fund trial
June 29, 2023
Wellcome and the Bill & Melinda Gates Foundation have announced funding to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical